Indegene Limited (NSE: INDGN)

Market Cap	153.20B
Revenue (ttm)	27.10B
Net Income (ttm)	3.73B
Shares Out	239.27M
EPS (ttm)	16.17
PE Ratio	39.59
Forward PE	38.87
Dividend	n/a
Ex-Dividend Date	n/a

Volume	326,122
Open	638.95
Previous Close	635.40
Day's Range	627.00 - 645.95
52-Week Range	470.10 - 736.30
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 31, 2024

About Indegene

Indegene Limited operates as a life sciences commercialization company in India, the United States, Europe, and internationally. It operates through three segments: Enterprise Medical Solutions, Enterprise Commercial Solutions, and Omnichannel Activation & Others. The company develops biotech and medical device for biopharmaceutical, emerging biotech, and medical device companies. It also offers enterprise commercial, medical, and clinical solutions; and omnichannel activation solutions. In addition, the company operates NEXT technology platfor...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 1998
• Employees: 4,367
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: INDGN

Financial Performance

In 2023, Indegene's revenue was 25.90 billion, an increase of 12.29% compared to the previous year's 23.06 billion. Earnings were 3.37 billion, an increase of 26.53%.